Wockhardt Ltd.

NSE: WOCKPHARMA | BSE: 532300 | ISIN: INE049B01025 |Industry: Pharmaceuticals
|Weak Stock
440.95 9.90 (2.30%)
NSE Dec 03, 2021 15:31 PM
Volume: 946.2K
 

Wockhardt Ltd.    
08 Nov 2021
440.95
2.30%

Highlights:

  • Q2 FY22 Revenue grew by 21% over Q2 FY21
  • EBITDA at Rs. 109 crore compared to a nominal profit of Rs. 27 crore in the corresponding quarter of the previous year.
  • Profit after Tax (PAT) for the Quarter was Rs. 34 crore against Rs. (13) crore in the previous quarter.
  • Net Debt-Equity ratio as on 30th September, 2021 stood at 0.54. 

 

 

Result PDF

default
Promoters pledged 7.55% of shares in last quarter. Total pledge stands at 41.99% of promoter holdings
Recommended
More from Wockhardt Ltd.